Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LRRC19—A Bridge between Selenium Adjuvant Therapy and Renal Clear Cell Carcinoma: A Study Based on Datamining

17 Apr 2020

Abstract excerpt

Kidney renal clear cell carcinoma (KIRC) is the most common and fatal subtype of renal cancer. Antagonistic associations between selenium and cancer have been reported in previous studies. Selenium compounds, as anti-cancer agents, have been reported and approved for clinical trials. The main active form of selenium in selenoproteins is selenocysteine (Sec). The process of Sec biosynthesis and incorporation into...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Glutathione Transferases and Polymorphisms
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32316597
DOI: 10.3390/genes11040440

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LRRC19—A Bridge between Selenium Adjuvant Therapy and Renal Clear Cell Carcinoma: A Study Based on DataminingPMID 32316597Read ↗

Identification of Oncosuppressing Effects of Seven Selenoproteins in Thyroid Cancer: Implications for Distinct Roles of Selenoproteins in TumorigenesisSemantic proximity Read ↗

Molecular mechanisms and prognostic value of the selenoprotein gene family in lung adenocarcinoma and lung squamous cell carcinomaSemantic proximity Read ↗

Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma TreatmentSemantic proximity Read ↗

Identification and Validation of a Novel Ferroptotic Prognostic Genes-Based Signature of Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosisSemantic proximity Read ↗

The emerging role of selenium metabolic pathways in cancer: New therapeutic targets for cancerSemantic proximity Read ↗

Current Landscape and the Potential Role of HIF and Selenium in Clear Cell Renal Cell Carcinoma TreatmentSemantic proximity Read ↗

Functional deficiency of succinate dehydrogenase promotes tumorigenesis and development of clear cell renal cell carcinoma through weakening of ferroptosisSemantic proximity Read ↗

The Deubiquitinase USP2 Inhibits Clear Cell Renal Cell Carcinoma by Activating the p53 Signaling Pathway and Inducing FerroptosisSemantic proximity Read ↗

“Alphabet” Selenoproteins: Implications in PathologySemantic proximity Read ↗

Metabolism of Selenium, Selenocysteine, and Selenoproteins in Ferroptosis in Solid Tumor CancersSemantic proximity Read ↗

The miR-21-5p, miR-30c-5p, and miR-182-5p as Biomarkers in Clear Cell Renal Cell Carcinoma: A Southeastern Romanian Cohort StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.